Antineoplastic Agents in Breast Cancers With Mutational Signatures
Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.
Source: Medscape Oncology - Category: Cancer & Oncology Authors: Medscape Source Type: podcasts